Autoinjector & Pen Injector Supply for South Asia
South Asia is a volume strategy: the region's insulin base is enormous, its generic pharma industry is a natural ODM customer, and its price discipline is the strictest we serve. Programs here are won on platform economics and manufacturing scale — with the same ISO 11608 evidence as every other market.
| Market | Device registration route | Key requirement | Suggested entry |
|---|---|---|---|
| India | CDSCO MD-15 device registration | Price-competitive platform economics | Volume pens, tied to leading generic pharma |
| Bangladesh | DGDA device registration | Local pharma partners | ODM combination programs |
| Pakistan | DRAP device registration | Price-sensitive channel | Combination ODM programs |
Where the value sits in a volume market
Volume programs reward configuration discipline: standard housings, platform cartridges, and packaging-level branding keep unit economics tight without touching validated parameters — the approach described in our [cost reduction guide](/articles/reduce-injector-cost.html). The A-60 (1–60 IU) and A-75 (1–75 IU) exist precisely for this profile: all-plastic adjustable pens with published specifications and durable mechanics.
How to verify us
Ask for the specification sheets, the compliance scope in writing and a written quotation at your volume band with the batch logic shown; certificate copies follow with the order documentation. Volume programs deserve the same document discipline as launch programs.
This page does not cover
Registration filings, distribution appointees and tender mechanics are your local team's work. Device documentation and platform economics are ours.
Planning a program for this region?
Send your container format, therapy area and target country — we return the platform match, the regional documentation set and written pricing within one working day.
Start the inquiry